Cite

MLA Citation

    F. Tinahones et al.. “Alirocumab efficacy and safety by body mass index: Pooled analysis from 10 Phase 3 ODYSSEY trials.” Atherosclerosis, vol. 275, 2018, pp. e53–e54. http://access.bl.uk/ark:/81055/vdc_100066562718.0x00005a
  
Back to record